← Back to Search

Procedure

PICC Placement for Peripheral Catheterization in Newborns

N/A

Recruiting

Led By Amuchou Soraisham, MD

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Peripherally inserted central venous catheter (PICC) line insertion planned as part of NICU care

Neonates of all gestational ages admitted to Foothills Medical Centre and Alberta Children's Hospital Neonatal Intensive Care Unit (NICU)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, within 4 weeks

Awards & highlights

Study Summary

This trial studies how PICC insertion site affects complications that require removal in newborns in the NICU.

Who is the study for?

This trial is for newborns of any gestational age in the NICU at Foothills Medical Centre and Alberta Children's Hospital who need a PICC line as part of their care. They must have available veins for insertion both above and below the umbilicus.Check my eligibility

What is being tested?

The study is looking into whether where the PICC line is put in (either upper or lower body) affects how often complications happen that make doctors have to take out the PICC line.See study design

What are the potential side effects?

While not explicitly listed, common side effects from PICC insertions can include infection, irritation at the insertion site, blood clots, and possibly injury to nerves or vessels near the insertion area.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My baby is in the NICU and will have a PICC line inserted.

Select...

My newborn is admitted to the NICU at Foothills Medical Centre or Alberta Children's Hospital.

Select...

I have veins in both my upper and lower body that can be used for medical procedures.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, within 4 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, within 4 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, within 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

is the presence of any complication which necessitates PICC removal

Secondary outcome measures

will be time to complication post insertion

Trial Design

2Treatment groups

Experimental Treatment

Group I: Upper Extremity InsertionExperimental Treatment1 Intervention

Peripherally Inserted Central Venous Cather (PICC) inserted in upper extremity

Group II: Lower Extremity InsertionExperimental Treatment1 Intervention

Peripherally Inserted Central Venous Cather (PICC) inserted in lower extremity

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor

792 Previous Clinical Trials

868,834 Total Patients Enrolled

Amuchou Soraisham, MDPrincipal InvestigatorUniversity of Calgary

Media Library

Peripherally Inserted Central Venous Cather (PICC) (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03474978 — N/A

Peripheral Catheterization Research Study Groups: Upper Extremity Insertion, Lower Extremity Insertion

Peripheral Catheterization Clinical Trial 2023: Peripherally Inserted Central Venous Cather (PICC) Highlights & Side Effects. Trial Name: NCT03474978 — N/A

Peripherally Inserted Central Venous Cather (PICC) (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03474978 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total number of participants in this clinical experiment?

"Indeed, clinicaltrials.gov is advertising this medical trial and its need for 320 patients at 1 site. The study was posted on October 19th 2018 and has been recently updated as of May 17th 2023."

Answered by AI

Is this medical research still accepting participants?

"Affirmative. Per the details provided on clinicaltrials.gov, this research is currently taking applications for participation. The trial was initially made public on October 19th 2018 and last modified on May 17th 2023. A total of 320 subjects are needed from one specific site.."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Peripherally Inserted Central Catheter Insertion Site and Complication Rate in Neonates

Amuchou Soraisham 2018. "Peripherally Inserted Central Catheter Insertion Site and Complication Rate in Neonates". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03474978.